Open Access and Peer-reviewed
Home Journal Issues Guide for Authors Editorial Board Aims & Scope About Journal News & Announcements


Original Research 


Impact of Gene Polymorphism of Lipoprotein Lipase on Atorvastatin Treatment Outcome in Ischemic Stroke Patient in Najaf Governorate

Sarah Ali Abbas, Ahmed M. AlMudhafar, Thekra A. Al-Kashwan, Hayder K Hasson, Adhwaa Hameed Jaber, Najah R Hadi.

Abstract
Background: Stroke was commonly identified as a neurologically impairment that occur in central nervous system on vascular basis as Acute focal injury. Statin (HMG-CoA reductase Inhibitor), clinical trials in many large scaled shown that in primary and secondary CVD the used of statin was declined rates of (CV). Human Lipoprotein Lipase (LPL) gene coding was place in short arm of chromosome in the p22 region of the same Chromosome and has nine introns and ten axons.
Aim: The aim of the study is to find out effect of LPL gene polymorphism of response to atorvastatin treatment in patients with ischemic stroke.
Patients and methods: Samples was Picking up from patientsí admission to at Middle Euphrates Center for Neurological Sciences in the main hospital for measurement of the lipid profile, molecular analysis study of genotyping and measurement of human lipoprotein lipase by ELISA technique.
Result: There is good response to treatment and the response consider statistically significant, the best group response to treatment was homozygous mutation then Heterozygous mutation and the less group response was Homozygous normal, wild.
Conclusion: The effect of drug on serum biomarker not affected by age except HDL (best result in age<60yr), and not affected by gender and weight state, while in consider to smoking and Hypertension TG (best response in non-smoker, hypertensive) and VLDL (best response in smoker, hypertensive) affected and in diabetic state the Cholesterol and TG affected on response (the best result in non-diabetic). Heterozygous mutation most distributed then homozygous normal and the less distributed was homozygous mutation.

Key words: atorvastatin, gene polymorphism, LPL


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Sarah Ali Abbas
Articles by Ahmed M. AlMudhafar
Articles by Thekra A. Al-Kashwan
Articles by Hayder K Hasson
Articles by Adhwaa Hameed Jaber
Articles by Najah R Hadi
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Abbas SA, AlMudhafar AM, Al-Kashwan TA, Hasson HK, Jaber AH, Hadi NR. Impact of Gene Polymorphism of Lipoprotein Lipase on Atorvastatin Treatment Outcome in Ischemic Stroke Patient in Najaf Governorate. doi:http://doi.org/10.31838/ejmcm.07.02.36


Web Style

Abbas SA, AlMudhafar AM, Al-Kashwan TA, Hasson HK, Jaber AH, Hadi NR. Impact of Gene Polymorphism of Lipoprotein Lipase on Atorvastatin Treatment Outcome in Ischemic Stroke Patient in Najaf Governorate. http://www.ejmcm.com/?mno=6535 [Access: October 13, 2020]. doi:http://doi.org/10.31838/ejmcm.07.02.36


AMA (American Medical Association) Style

Abbas SA, AlMudhafar AM, Al-Kashwan TA, Hasson HK, Jaber AH, Hadi NR. Impact of Gene Polymorphism of Lipoprotein Lipase on Atorvastatin Treatment Outcome in Ischemic Stroke Patient in Najaf Governorate. doi:http://doi.org/10.31838/ejmcm.07.02.36



Vancouver/ICMJE Style

Abbas SA, AlMudhafar AM, Al-Kashwan TA, Hasson HK, Jaber AH, Hadi NR. Impact of Gene Polymorphism of Lipoprotein Lipase on Atorvastatin Treatment Outcome in Ischemic Stroke Patient in Najaf Governorate. doi:http://doi.org/10.31838/ejmcm.07.02.36



Harvard Style

Abbas, S. A., AlMudhafar, . A. M., Al-Kashwan, . T. A., Hasson, . H. K., Jaber, . A. H. & Hadi, . N. R. (2020) Impact of Gene Polymorphism of Lipoprotein Lipase on Atorvastatin Treatment Outcome in Ischemic Stroke Patient in Najaf Governorate. doi:http://doi.org/10.31838/ejmcm.07.02.36



Turabian Style

Abbas, Sarah Ali, Ahmed M. AlMudhafar, Thekra A. Al-Kashwan, Hayder K Hasson, Adhwaa Hameed Jaber, and Najah R Hadi. 2020. Impact of Gene Polymorphism of Lipoprotein Lipase on Atorvastatin Treatment Outcome in Ischemic Stroke Patient in Najaf Governorate. doi:http://doi.org/10.31838/ejmcm.07.02.36



Chicago Style

Abbas, Sarah Ali, Ahmed M. AlMudhafar, Thekra A. Al-Kashwan, Hayder K Hasson, Adhwaa Hameed Jaber, and Najah R Hadi. "Impact of Gene Polymorphism of Lipoprotein Lipase on Atorvastatin Treatment Outcome in Ischemic Stroke Patient in Najaf Governorate." doi:http://doi.org/10.31838/ejmcm.07.02.36



MLA (The Modern Language Association) Style

Abbas, Sarah Ali, Ahmed M. AlMudhafar, Thekra A. Al-Kashwan, Hayder K Hasson, Adhwaa Hameed Jaber, and Najah R Hadi. "Impact of Gene Polymorphism of Lipoprotein Lipase on Atorvastatin Treatment Outcome in Ischemic Stroke Patient in Najaf Governorate." doi:http://doi.org/10.31838/ejmcm.07.02.36



APA (American Psychological Association) Style

Abbas, S. A., AlMudhafar, . A. M., Al-Kashwan, . T. A., Hasson, . H. K., Jaber, . A. H. & Hadi, . N. R. (2020) Impact of Gene Polymorphism of Lipoprotein Lipase on Atorvastatin Treatment Outcome in Ischemic Stroke Patient in Najaf Governorate. doi:http://doi.org/10.31838/ejmcm.07.02.36








AUTHOR LOGIN

REVIEWER LOGIN

Indexed
&
Abstracted


Journal is indexed by the following services:

Scopus
CrossRef
JISC KB+
SHERPA RoMEO
Cengage Learning
Directory of Open Access Journals (DOAJ)
Google Scholar

In addition, all journals are available for harvesting via OAI-PMH.


ABOUT JOURNAL
POLICIES
STATEMENTS

This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author. This is in accordance with the Budapest Open Access Initiative (BOAI) definition of open access.

The articles in European Journal of Molecular & Clinical Medicine are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc-sa/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.